OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Preclinical Evaluation, and Clinical Translation of⁶⁸Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma
Liang Zhao, Yizhen Pang, Jianyang Fang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 3, pp. 394-401
Open Access | Times Cited: 13

Showing 13 citing articles:

Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 12

Radiopharmaceuticals in nasopharyngeal Cancer
Xiao‐Quan Xu, Xuemei Tang, Wan-yin Wu, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108281-108281
Closed Access | Times Cited: 1

Development and Evaluation of Novel ⁶⁸Ga/¹⁷⁷Lu-Labeled PSMA Inhibitors with Enhanced Pharmacokinetics and Tumor Imaging for Prostate Cancer
Haiyang Li, Yang Liu, Hongmei Yuan, et al.
Molecular Pharmaceutics (2025)
Closed Access

Multivalent FAPI-based radiopharmaceuticals in PET/CT: from cancer diagnostics to theranostics
Tao-Qian Zhao
American Journal of Nuclear Medicine and Molecular Imaging (2025) Vol. 15, Iss. 2, pp. 82-86
Closed Access

Development of a PSMA and EphA2 dual-receptor-activated fluorescent probe for wash-free prostate cancer cell imaging
Xiaoyun Pan, Xiao Wang, Yijing Zhang, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 125, pp. 118217-118217
Closed Access

Approaching Gallium-68 radiopharmaceuticals for tumor diagnosis: a Medicinal Chemist’s perspective
Francesca Musumeci, Alessandro Fasce, Marta Falesiedi, et al.
European Journal of Medicinal Chemistry (2025) Vol. 294, pp. 117760-117760
Closed Access

Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy
Yihui Luo, Haitian Fu, Chunjing Yu
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives
Ziyue Yu, Zeng Jiang, Xuebo Cheng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116787-116787
Closed Access | Times Cited: 3

Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma
Jianhao Chen, Yizhen Pang, Xiyi Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 52, Iss. 1, pp. 247-259
Closed Access | Times Cited: 2

Enhanced Detection of Early Pulmonary Fibrosis Disease Using ⁶⁸Ga-FAPI-LM3 PET
Jianhao Chen, Doudou Luo, Yaqing Dai, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3684-3692
Closed Access | Times Cited: 2

Design, preclinical evaluation, and first-in-human PET study of [68Ga]Ga-PSFA-01: a PSMA/FAP heterobivalent tracer
Xinlin Wang, Xiaoyang Zhang, Xiaojun Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access | Times Cited: 1

Rational Modifications on N-(4-Quinolinoyl)-Gly-2-Cyanopyrrolidine to Develop Fibroblast Activation Protein-Targeted Radioligands with Improved Affinity and Tumor Uptake
Xiayang Qiu, Qianqian Gan, Tianxiong Ji, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117011-117011
Closed Access

Elucidating the linagliptin and human fibroblast activation protein binding mechanism through molecular dynamics and binding free energy analysis
Mingsong Shi, Fang Wang, Lu Zhou, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111368-111368
Open Access

Preclinical Study of a Dual-Target Molecular Probe Labeled with 68Ga Targeting SSTR2 and FAP
Huanhuan Liu, Xiaojun Zhang, Yue Pan, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1647-1647
Open Access

Current Status and Perspectives of Novel Radiopharmaceuticals with Heterologous Dual-targeted Functions: 2013–2023
Zuojie Li, Qing Ruan, Yuhao Jiang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 13 citing articles:

Your Privacy